• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Science: A single mutation in bovine influenza H5N1 hemagglutinin switches specificity to human receptors

Shiloh

Editor, Senior Moderator
Source: https://www.science.org/doi/10.1126/science.adt0180

A single mutation in bovine influenza H5N1 hemagglutinin switches specificity to human receptors

Ting-Hui Lin https://orcid.org/0000-0002-0937-9972, Xueyong Zhu https://orcid.org/0000-0002-6021-3740, Shengyang Wang https://orcid.org/0000-0002-8454-1255, Ding Zhang https://orcid.org/0009-0001-1057-0256, Ryan McBride https://orcid.org/0000-0001-8616-1910, Wenli Yu https://orcid.org/0000-0002-4025-2646, Simeon Babarinde https://orcid.org/0000-0001-5603-4769, James C. Paulson https://orcid.org/0000-0003-4589-5322 , and Ian A. Wilson https://orcid.org/0000-0002-6469-2419 Authors Info & Affiliations
Science
5 Dec 2024
Vol 386, Issue 6726
pp. 1128-1134

Editor’s summary
In 2021, a highly pathogenic influenza H5N1 clade 2.3.4.4b virus was detected in North America that is capable of infecting a diversity of avian species, marine mammals, and humans. In 2024, clade 2.3.4.4b virus spread widely in dairy cattle in the US, causing a few mild human cases, but retaining specificity for avian receptors. Historically, this virus has caused up to 30% fatality in humans, so Lin et al. performed a genetic and structural analysis of the mutations necessary to fully switch host receptor recognition. A single glutamic acid to leucine mutation at residue 226 of the virus hemagglutinin was sufficient to enact the change from avian to human specificity. In nature, the occurrence of this single mutation could be an indicator of human pandemic risk. —Caroline Ash​

Abstract
In 2024, several human infections with highly pathogenic clade 2.3.4.4b bovine influenza H5N1 viruses in the United States raised concerns about their capability for bovine-to-human or even human-to-human transmission. In this study, analysis of the hemagglutinin (HA) from the first-reported human-infecting bovine H5N1 virus (A/Texas/37/2024, Texas) revealed avian-type receptor binding preference. Notably, a Gln226Leu substitution switched Texas HA binding specificity to human-type receptors, which was enhanced when combined with an Asn224Lys mutation. Crystal structures of the Texas HA with avian receptor analog LSTa and its Gln226Leu mutant with human receptor analog LSTc elucidated the structural basis for this preferential receptor recognition. These findings highlight the need for continuous surveillance of emerging mutations in avian and bovine clade 2.3.4.4b H5N1 viruses.​


 
Back
Top